PROGRAM

TCT 2019 will feature a host of sponsored satellite programs offering attendees comprehensive insights into important interventional topics and issues facing interventional specialists. 

Sponsored sessions include breakfast programs, lunchtime Presentation Theater programs, and evening programming. 

Satellite Programs

Aspirin for the Interventionalist: More Than Meets the Eye

Breakfast Program

09/28/2019 06:45:00 09/28/2019 07:45:00 Aspirin for the Interventionalist: More Than Meets the Eye TCT 2017 true MM/DD/YYYY TCT 2014 Satellite Symposia - Breakfast Program

Saturday, September 28, 2019
Breakfast: 6:30 am  | 
Program: 6:45 am-7:45 am
The Moscone Center, Room 211, Level 2, Moscone South

Aspirin for the Interventionalist: More Than Meets the Eye

Aspirin for the Interventionalist: More Than Meets the Eye

Sponsored by Cardiovascular Research Foundation

Supported through an educational grant from PLx Pharma

The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cardiovascular Research Foundation designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Chair  

Gregg W. Stone, MD

NewYork-Presbyterian/ Columbia University Medical Center

New York, NY

Faculty  

Dominick J. Angiolillo, MD, PhD

University of Florida

Jacksonville, FL

 

C.Michael Gibson, MD, MD

Beth Israel Deaconess Medical Center

Boston, MA

 

Sanjit S. Jolly, MD, MSc

Hamilton General Hospital

Hamilton, Canada

 

Kenneth W. Mahaffey, MD

Stanford University School of Medicine

Stanford, CA

 

Freek Verheugt, MD

Onze Lieve Vrouwe Gasthuis (OLVG)

Amsterdam, The Netherlands

Agenda

6:45 am

Aspirin: Variability Mechanisms of Action and Clinical Relevance

Dominick J. Angiolillo

6:55 am

Does Aspirin Formulation Matter? Aspirin Bioavailability and Safety/Effectiveness With Different Formulations

7:05 am

Interactions Between Aspirin and P2Y12 Inhibitors: Mechanistic and Clinical Effects

Kenneth W. Mahaffey

7:15 am

Reducing Aspirin Use in ACS and PCI (With and Without Afib): How Good is the Evidence?

C.Michael Gibson

7:25 am

Evidence for Chronic Aspirin Use in CV Patients: COMPASS and More

Sanjit S. Jolly

7:35 am

How to Integrate Aspirin in ACS and After PCI: Roundtable Discussion With Audience Q&A

7:45 am

Adjourn